Home Media News
News October 09, 2024 2 min read
Advancing Breast Cancer Screening with AI Technology

Advancing Breast Cancer Screening with AI Technology

In a review published by the European Journal of Radiology, researchers explored the potential of Artificial Intelligence (AI) to revolutionize breast cancer screening through advancements in digital mammography (DM) and digital breast tomosynthesis (DBT).

P
PAICON
From Data to Diagnostics
AI in breast cancer Breast Cancer Screening Digital Mammography
Share:

In a review published by the European Journal of Radiology, researchers explored the potential of Artificial Intelligence (AI) to revolutionize breast cancer screening through advancements in digital mammography (DM) and digital breast tomosynthesis (DBT).

Key Findings and Challenges

Deep Learning (DL)-based AI systems have shown considerable promise, significantly enhancing detection accuracy and reducing the workload for radiologists. With improved capabilities to identify subtle abnormalities, AI has demonstrated an ability to both reduce false positives and negatives, providing more consistent results and potentially surpassing traditional computer-aided detection (CAD) systems.

However, while AI systems offer substantial benefits, this review highlights several challenges. Issues such as data quality, potential biases in training data, and regulatory complexities are significant barriers to the broader clinical adoption of AI in breast imaging. Moreover, the article emphasizes the importance of standardized guidelines and reliable practices, such as the FUTURE-AI framework, to build clinical trust and ensure fairness, robustness, and explainability in AI applications.

The Future of AI in Breast Cancer Screening

With standardized guidelines, increased collaboration among researchers, and adherence to trustworthy AI practices, AI technology could significantly advance the accuracy, fairness, and reliability of breast cancer screenings worldwide. Ongoing efforts, like federated learning, aim to enhance the quality and generalizability of AI models, ensuring robust clinical performance across diverse populations.

The integration of AI in breast cancer screening is poised to be a major leap forward. However, continuous research, clinical trials, and regulatory guidance will be essential to fully unlock AI’s potential in healthcare. This review highlights the collaborative efforts needed to bring these transformative technologies into routine practice, ultimately improving patient outcomes and empowering healthcare providers.

Read the full article for more details

Reference

Díaz, O., Rodríguez-Ruíz, A., & Sechopoulos, I. (2024). Artificial intelligence for breast cancer detection: Technology, challenges, and prospects. European Journal of Radiology, 175, 111457. https://doi.org/10.1016/j.ejrad.2024.111457

Subscribe to Our Monthly Newsletter

Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.

We respect your privacy. Unsubscribe at any time.